Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Glucose, insulin, and free fatty acid metabolism in Parkinson's disease treated with levodopa.

× No keyword cloud information.

17 in total

Review 1. Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part II).

Authors: S O'Byrne; J Feely
Journal: Drugs Date: 1990-08 Impact factor: 9.546

Review 2. Minireview: Dopaminergic regulation of insulin secretion from the pancreatic islet.

Authors: Alessandro Ustione; David W Piston; Paul E Harris
Journal: Mol Endocrinol Date: 2013-06-06

Review 3. Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors: R N Brogden; T M Speight; G S Avery
Journal: Drugs Date: 1971 Impact factor: 9.546

4. Prolonged levodopa therapy.

Authors:
Journal: Br Med J Date: 1973-02-17

5. Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.

Authors: J R Bianchine; L Sunyapridakul
Journal: Drugs Date: 1973 Impact factor: 9.546

6. Studies on some metabolic effects of dopa and dopamine in the rat.

Authors: P J Neuvonen; E Westermann
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1974 Impact factor: 3.000

Review 7. The hypothalamus in Parkinson disease.

Authors: R Sandyk; R P Iacono; C R Bamford
Journal: Ital J Neurol Sci Date: 1987-06

8. Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinson's Disease.

Authors: L Hunter Randy; Bing Guoying
Journal: Curr Neuropharmacol Date: 2007-03 Impact factor: 7.363

9. Diabetes is associated with postural instability and gait difficulty in Parkinson disease.

Authors: Vikas Kotagal; Roger L Albin; Martijn L T M Müller; Robert A Koeppe; Kirk A Frey; Nicolaas I Bohnen
Journal: Parkinsonism Relat Disord Date: 2013-02-23 Impact factor: 4.891

Review 10. Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer's Disease and Other Neurodegenerative Diseases.

Authors: Valeria Calsolaro; Paul Edison
Journal: CNS Drugs Date: 2015-12 Impact factor: 5.749